释放免疫检查点的力量:新型分子的翻译后修改和临床应用
Jie Wang1, Yian Wang2, Xianjie Jiang3
1Department of Pathology, Institute of Oncology & Diagnostic Pathology Center, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Cancer letters
|February 24, 2024
概括
像TIM3和LAG3这样的新型免疫检查点提供了超越PD-1/PD-L1和CTLA-4的新治疗点. 翻译后的修改调节了这些检查点,影响了它们在癌症免疫治疗中的临床应用.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 免疫检查点调节免疫反应,但瘤利用它们来逃避免疫.
- 目前针对PD-1/PD-L1和CTLA-4的治疗方法有希望,但在疗效和耐药性方面存在局限性.
- 新兴的研究重点是新型免疫检查点及其调节机制.
研究的目的:
- 审查超越PD-1/PD-L1和CTLA-4的新型免疫检查点分子.
- 探索翻译后修改在调节免疫检查点中的作用.
- 讨论针对新型免疫检查点及其修改的临床潜力.
主要方法:
- 关于免疫检查点的临床前和临床研究的文献综述.
- 对新型免疫检查点和连接体的结构特征的分析.
- 检查影响免疫检查点的翻译后修改途径.
主要成果:
- 识别了几个新的免疫检查点 (TIM3,LAG3,TIGIT,NKG2D,CD47) 和它们的配体.
- 阐明各种翻译后的修饰 (糖化,化,无处不在化等). 控制检查点的功能.
- 强调这些修改与检查点法规之间的复杂联系.
结论:
- 新型免疫检查点代表了克服当前免疫治疗局限性的有希望的目标.
- 了解翻译后修改对于优化免疫检查点封锁策略至关重要.
- 针对这些新的检查点及其修改,有可能改善癌症治疗结果.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Regulation of Expression at Multiple Steps
907
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
907


